Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clinical Genomics Laboratory, |
RCV005052307 | SCV005685487 | uncertain significance | MYCBP2-related developmental delay with corpus callosum defects | 2024-07-22 | criteria provided, single submitter | clinical testing | The MYCBP2 c.1370_1372del (p.Glu457del) variant, to our knowledge, has not been reported in the medical literature. The highest population minor allele frequency in the population database genome aggregation database (v.2.1.1) is 0.0213% in the European non-Finnish population, however, no homozygotes were identified. This variant is predicted to cause a change in the length of the protein due to an in-frame deletion of one amino acid in a non-repeat region. Due to limited information, the clinical significance of this variant is uncertain. |